The global Pharmaceutical Contract Development and Manufacturing market is projected to grow from US$ 130110 million in 2024 to US$ 188680 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.

Pharmaceutical Contract Development and Manufacturing Market

Market Analysis and Insights: Global Pharmaceutical Contract Development and Manufacturing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Pharmaceutical Contract Development and Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pharmaceutical Contract Development and Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutical Contract Development and Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Contract Development and Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutical Contract Development and Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutical Contract Development and Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pharmaceutical Contract Development and Manufacturing Market Report

Report Metric	Details
Report Name	Pharmaceutical Contract Development and Manufacturing Market
Accounted market size in 2024	US$ 130110 million
Forecasted market size in 2030	US$ 188680 million
CAGR	6.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Pharmaceutical Manufacturing Services Biologics Manufacturing Services Drug Development Services
Segment by Application	Big Pharma Small Pharma Generic Pharma CRO
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group, Consort Medical plc, Almac Group, Siegfried Holding AG, Boehringer Ingelheim International GmbH, Evonik Industries AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pharmaceutical Contract Development and Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Contract Development and Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Contract Development and Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Pharmaceutical Contract Development and Manufacturing Market growing?

Ans: The Pharmaceutical Contract Development and Manufacturing Market witnessing a CAGR of 6.4 during the forecast period 2025-2030.

What is the Pharmaceutical Contract Development and Manufacturing Market size in 2030?

Ans: The Pharmaceutical Contract Development and Manufacturing Market size in 2030 will be US$ 188680 million.

Who are the main players in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The main players in the Pharmaceutical Contract Development and Manufacturing Market are Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group, Consort Medical plc, Almac Group, Siegfried Holding AG, Boehringer Ingelheim International GmbH, Evonik Industries AG

What are the Application segmentation covered in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The Applications covered in the Pharmaceutical Contract Development and Manufacturing Market report are Big Pharma, Small Pharma, Generic Pharma, CRO

What are the Type segmentation covered in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The Types covered in the Pharmaceutical Contract Development and Manufacturing Market report are Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Pharmaceutical Manufacturing Services

1.2.3 Biologics Manufacturing Services

1.2.4 Drug Development Services

1.3 Market by Application

1.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Big Pharma

1.3.3 Small Pharma

1.3.4 Generic Pharma

1.3.5 CRO

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Contract Development and Manufacturing Market Perspective (2019-2030)

2.2 Global Pharmaceutical Contract Development and Manufacturing Growth Trends by Region

2.2.1 Pharmaceutical Contract Development and Manufacturing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Size by Region (2019-2024)

2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2025-2030)

2.3 Pharmaceutical Contract Development and Manufacturing Market Dynamics

2.3.1 Pharmaceutical Contract Development and Manufacturing Industry Trends

2.3.2 Pharmaceutical Contract Development and Manufacturing Market Drivers

2.3.3 Pharmaceutical Contract Development and Manufacturing Market Challenges

2.3.4 Pharmaceutical Contract Development and Manufacturing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Pharmaceutical Contract Development and Manufacturing by Players

3.1.1 Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2019-2024)

3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2019-2024)

3.2 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Pharmaceutical Contract Development and Manufacturing, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio

3.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2023

3.5 Global Key Players of Pharmaceutical Contract Development and Manufacturing Head office and Area Served

3.6 Global Key Players of Pharmaceutical Contract Development and Manufacturing, Product and Application

3.7 Global Key Players of Pharmaceutical Contract Development and Manufacturing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Type

4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2019-2024)

4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2025-2030)

5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application

5.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Application (2019-2024)

5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)

6.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type

6.2.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024)

6.2.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030)

6.2.3 North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application

6.3.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024)

6.3.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030)

6.3.3 North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country

6.4.1 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)

6.4.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)

7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type

7.2.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024)

7.2.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030)

7.2.3 Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application

7.3.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024)

7.3.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030)

7.3.3 Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country

7.4.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)

7.4.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)

8.2 China Pharmaceutical Contract Development and Manufacturing Market Size by Type

8.2.1 China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024)

8.2.2 China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030)

8.2.3 China Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

8.3 China Pharmaceutical Contract Development and Manufacturing Market Size by Application

8.3.1 China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024)

8.3.2 China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030)

8.3.3 China Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)

9.2 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type

9.2.1 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024)

9.2.2 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030)

9.2.3 Asia Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

9.3 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application

9.3.1 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024)

9.3.2 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030)

9.3.3 Asia Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

9.4 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region

9.4.1 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024)

9.4.3 Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type

10.2.1 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application

10.3.1 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country

10.4.1 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Thermo Fisher Scientific Inc.

11.1.1 Thermo Fisher Scientific Inc. Company Details

11.1.2 Thermo Fisher Scientific Inc. Business Overview

11.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction

11.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.1.5 Thermo Fisher Scientific Inc. Recent Developments

11.2 Catalent, Inc.

11.2.1 Catalent, Inc. Company Details

11.2.2 Catalent, Inc. Business Overview

11.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction

11.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.2.5 Catalent, Inc. Recent Developments

11.3 Lonza Group Ltd

11.3.1 Lonza Group Ltd Company Details

11.3.2 Lonza Group Ltd Business Overview

11.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction

11.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.3.5 Lonza Group Ltd Recent Developments

11.4 Recipharm AB

11.4.1 Recipharm AB Company Details

11.4.2 Recipharm AB Business Overview

11.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction

11.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.4.5 Recipharm AB Recent Developments

11.5 Vetter Pharma International GMBH

11.5.1 Vetter Pharma International GMBH Company Details

11.5.2 Vetter Pharma International GMBH Business Overview

11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction

11.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.5.5 Vetter Pharma International GMBH Recent Developments

11.6 FAMAR Health Care Services

11.6.1 FAMAR Health Care Services Company Details

11.6.2 FAMAR Health Care Services Business Overview

11.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction

11.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.6.5 FAMAR Health Care Services Recent Developments

11.7 AbbVie Inc.

11.7.1 AbbVie Inc. Company Details

11.7.2 AbbVie Inc. Business Overview

11.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction

11.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.7.5 AbbVie Inc. Recent Developments

11.8 Aenova Group

11.8.1 Aenova Group Company Details

11.8.2 Aenova Group Business Overview

11.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction

11.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.8.5 Aenova Group Recent Developments

11.9 Consort Medical plc

11.9.1 Consort Medical plc Company Details

11.9.2 Consort Medical plc Business Overview

11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction

11.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.9.5 Consort Medical plc Recent Developments

11.10 Almac Group

11.10.1 Almac Group Company Details

11.10.2 Almac Group Business Overview

11.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction

11.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.10.5 Almac Group Recent Developments

11.11 Siegfried Holding AG

11.11.1 Siegfried Holding AG Company Details

11.11.2 Siegfried Holding AG Business Overview

11.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction

11.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.11.5 Siegfried Holding AG Recent Developments

11.12 Boehringer Ingelheim International GmbH

11.12.1 Boehringer Ingelheim International GmbH Company Details

11.12.2 Boehringer Ingelheim International GmbH Business Overview

11.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction

11.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.12.5 Boehringer Ingelheim International GmbH Recent Developments

11.13 Evonik Industries AG

11.13.1 Evonik Industries AG Company Details

11.13.2 Evonik Industries AG Business Overview

11.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction

11.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

11.13.5 Evonik Industries AG Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific Inc

Catalent

Lonza Group Ltd

Recipharm

Vetter Pharma International GmbH

Famar Health Care Services

Boehringer Ingelheim International GmbH

Evonik Industries AG

List of Tables

Table 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Pharmaceutical Manufacturing Services

Table 3. Key Players of Biologics Manufacturing Services

Table 4. Key Players of Drug Development Services

Table 5. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2019-2024)

Table 9. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2025-2030)

Table 11. Pharmaceutical Contract Development and Manufacturing Market Trends

Table 12. Pharmaceutical Contract Development and Manufacturing Market Drivers

Table 13. Pharmaceutical Contract Development and Manufacturing Market Challenges

Table 14. Pharmaceutical Contract Development and Manufacturing Market Restraints

Table 15. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Players (2019-2024)

Table 17. Global Top Pharmaceutical Contract Development and Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2023)

Table 18. Global Pharmaceutical Contract Development and Manufacturing Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Headquarters and Area Served

Table 21. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Product and Application

Table 22. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2019-2024)

Table 26. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2025-2030)

Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Application (2019-2024)

Table 30. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Application (2025-2030)

Table 32. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Pharmaceutical Contract Development and Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Pharmaceutical Contract Development and Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Pharmaceutical Contract Development and Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Pharmaceutical Contract Development and Manufacturing Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2025-2030) & (US$ Million)

Table 64. Thermo Fisher Scientific Inc. Company Details

Table 65. Thermo Fisher Scientific Inc. Business Overview

Table 66. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product

Table 67. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 68. Thermo Fisher Scientific Inc. Recent Developments

Table 69. Catalent, Inc. Company Details

Table 70. Catalent, Inc. Business Overview

Table 71. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product

Table 72. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 73. Catalent, Inc. Recent Developments

Table 74. Lonza Group Ltd Company Details

Table 75. Lonza Group Ltd Business Overview

Table 76. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product

Table 77. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 78. Lonza Group Ltd Recent Developments

Table 79. Recipharm AB Company Details

Table 80. Recipharm AB Business Overview

Table 81. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product

Table 82. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 83. Recipharm AB Recent Developments

Table 84. Vetter Pharma International GMBH Company Details

Table 85. Vetter Pharma International GMBH Business Overview

Table 86. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product

Table 87. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 88. Vetter Pharma International GMBH Recent Developments

Table 89. FAMAR Health Care Services Company Details

Table 90. FAMAR Health Care Services Business Overview

Table 91. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product

Table 92. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 93. FAMAR Health Care Services Recent Developments

Table 94. AbbVie Inc. Company Details

Table 95. AbbVie Inc. Business Overview

Table 96. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product

Table 97. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 98. AbbVie Inc. Recent Developments

Table 99. Aenova Group Company Details

Table 100. Aenova Group Business Overview

Table 101. Aenova Group Pharmaceutical Contract Development and Manufacturing Product

Table 102. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 103. Aenova Group Recent Developments

Table 104. Consort Medical plc Company Details

Table 105. Consort Medical plc Business Overview

Table 106. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product

Table 107. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 108. Consort Medical plc Recent Developments

Table 109. Almac Group Company Details

Table 110. Almac Group Business Overview

Table 111. Almac Group Pharmaceutical Contract Development and Manufacturing Product

Table 112. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 113. Almac Group Recent Developments

Table 114. Siegfried Holding AG Company Details

Table 115. Siegfried Holding AG Business Overview

Table 116. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product

Table 117. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 118. Siegfried Holding AG Recent Developments

Table 119. Boehringer Ingelheim International GmbH Company Details

Table 120. Boehringer Ingelheim International GmbH Business Overview

Table 121. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product

Table 122. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 123. Boehringer Ingelheim International GmbH Recent Developments

Table 124. Evonik Industries AG Company Details

Table 125. Evonik Industries AG Business Overview

Table 126. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product

Table 127. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2019-2024) & (US$ Million)

Table 128. Evonik Industries AG Recent Developments

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2023 VS 2030

Figure 3. Pharmaceutical Manufacturing Services Features

Figure 4. Biologics Manufacturing Services Features

Figure 5. Drug Development Services Features

Figure 6. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2023 VS 2030

Figure 8. Big Pharma Case Studies

Figure 9. Small Pharma Case Studies

Figure 10. Generic Pharma Case Studies

Figure 11. CRO Case Studies

Figure 12. Pharmaceutical Contract Development and Manufacturing Report Years Considered

Figure 13. Global Pharmaceutical Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Pharmaceutical Contract Development and Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region: 2023 VS 2030

Figure 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2023

Figure 17. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2023

Figure 19. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

Figure 21. North America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

Figure 22. North America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)

Figure 23. United States Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

Figure 27. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

Figure 28. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)

Figure 29. Germany Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Pharmaceutical Contract Development and Manufacturing Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

Figure 37. China Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

Figure 38. Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

Figure 40. Asia Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

Figure 41. Asia Pharmaceutical Contract Development and Manufacturing Market Share by Region (2019-2030)

Figure 42. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2019-2030)

Figure 52. Brazil Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 59. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 60. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 61. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 62. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 63. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 64. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 65. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 66. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 67. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 68. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 69. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 70. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Contract Manufacturing Organization Services Market Insights Forecast to 2030

Global Purchasing Outsourcing Market Insights Forecast to 2030

Global Drug Delivery in Cancer Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Contract Sterilization Service Market Insights Forecast to 2030

Global Additive Manufacturing in Healthcare Market Insights Forecast to 2030

Global Strategic Sourcing Software Market Insights Forecast to 2030

Global Delivery Scheduling Software Market Insights Forecast to 2030

Global Application Development and Integration Market Insights Forecast to 2030

Workforce Scheduling Software Market

Global Prescription Writing Software Market Insights Forecast to 2030

Global Drilling Contractor Market Insights Forecast to 2030

Global IT Development Market Insights Forecast to 2030

Global IIoT Platforms for Manufacturing Market Insights Forecast to 2030

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Application Development Life Cycle Management Market Insights Forecast to 2030

Enterprise High Productivity Application Platform as a Service Market

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

RELATED REPORTS

Global Herbal Capsule Products Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22V13305

Fri May 23 00:00:00 UTC 2025

Add to Cart

Global PD-1 and PD-L1 Drug Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39H13383

Fri May 23 00:00:00 UTC 2025

Add to Cart

Global NBL1 ELISA Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13T13366

Fri May 23 00:00:00 UTC 2025

Add to Cart

Global Dopamine Transporter Monoclonal Antibody Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O13370

Fri May 23 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions